12 results match your criteria: "Levine Cancer Institute at Atrium Health[Affiliation]"
Int J Gynecol Cancer
September 2023
Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
BMJ Qual Saf
October 2023
Medicine, Division of Hematology, Levine Cancer Institute at Atrium Health, Charlotte, North Carolina, USA.
Hydroxyurea (HU) is an effective but underused disease-modifying therapy for patients with sickle cell anaemia (SCA). EMBRACE SCD, a sickle cell disease treatment demonstration project, aimed to improve access to HU by increasing prescription (Rx) rates by at least 10% from baseline in children with SCA.The Model for Improvement was used as the quality improvement framework.
View Article and Find Full Text PDFGynecol Oncol
November 2022
Department of Obstetrics & Gynecology, University of Wisconsin - Madison, 600 Highland Drive, Madison, WI 53792, United States of America.
Objectives: We describe post-operative complications after cytoreductive surgery with and without splenectomy for Stage III or IV epithelial ovarian cancer, and identify areas for quality improvement in post-splenectomy care.
Methods: All patients with ovarian cancer cytoreductive surgery from 2008 to 2018 were identified using an institutional database Gynecologic Oncology Longitudinal Data Collection and Utilization Program (GOLD CUP). We compared patients who had and did not have splenectomy as part of cytoreductive surgery by demographics, comorbidities, stage, operative and post-operative data, readmission rates, progression free survival, overall survival and death from disease.
Obstet Gynecol Clin North Am
June 2022
Division of Gynecologic Oncology, Levine Cancer Institute at Atrium Health, 1021 Morehead Medical Drive, Suite 2100, Charlotte, NC 28204, USA.
Gynecologic laparoscopy is a safe and effective route of surgery for many types of procedures. The potential for injury does exist, and prevention and timely recognition of complications are essential for maintaining the quality and safety of minimally invasive surgical procedures. Each facet of care, including preoperative preparation, appropriate patient positioning, trocar placement, and surgical technique, is reviewed, and recommendations are made to facilitate the performance of safe surgery and immediate recognition of complications if they do arise.
View Article and Find Full Text PDFJ Clin Oncol
February 2022
University of Virginia Medical Center, Charlottesville, VA.
Purpose: To provide guidance to clinicians regarding therapy for patients with brain metastases from solid tumors.
Methods: ASCO convened an Expert Panel and conducted a systematic review of the literature.
Results: Thirty-two randomized trials published in 2008 or later met eligibility criteria and form the primary evidentiary base.
J Natl Cancer Inst
June 2022
Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
Background: Trials of immune checkpoint inhibitors (ICIs) have published patient-reported quality of life (QOL), but the size and heterogeneity of this literature can make patient education difficult. This meta-analysis aimed to describe change in QOL and symptomatology in patients receiving ICIs for cancer.
Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, databases were searched through November 2019 for articles or abstracts of prospective, original studies reporting longitudinal QOL in adult cancer patients treated with ICIs.
J Urol
December 2021
Department of Urology, Main Line Health, Bryn Mawr, Pennsylvania.
J Urol
December 2021
Department of Urology, Main Line Health, Bryn Mawr, Pennsylvania.
Purpose: The interaction between sources of industrial byproducts and environmental pollutants (IBP/EP) and the prevalence of urothelial carcinoma (UC) in surrounding communities has been infrequently explored. The purpose of this research is to identify microregional UC hotspots and associated industrial and environmental risk factors.
Materials And Methods: We retrospectively queried a multi-institutional database for UC patients diagnosed between 2008 and 2018.
J Med Internet Res
March 2020
H Lee Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, United States.
Background: Measuring patient-reported outcomes (PROs) requires an individual's perspective on their symptoms, functional status, and quality of life. Digital health enables remote electronic PRO (ePRO) assessments as a clinical decision support tool to facilitate meaningful provider interactions and personalized treatment.
Objective: This study explored the feasibility and acceptability of collecting ePROs using validated health-related quality of life (HRQoL) questionnaires for prostate cancer.
J Minim Invasive Gynecol
January 2020
Levine Cancer Institute at Atrium Health, Charlotte, North Carolina (Drs. Brown, Drury, Naumann, and Mr. Raub).
Study Objective: To characterize workplace and sexual harassment and discrimination among physicians in gynecology.
Design: A beta-tested Internet survey was distributed by e-mail using the REDCap platform. All responses were anonymous.
J Neurooncol
November 2018
Department of Radiation Oncology, Sidney Kimmel Medical College and Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.
Background: Glioblastoma predominantly occurs in the 6th and 7th decades of life. The optimal treatment paradigm for elderly patients is not well established. We sampled current worldwide management strategies for elderly patients with newly diagnosed glioblastoma.
View Article and Find Full Text PDF